Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.6 (
CAD
)
4,420
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Atherosclerosis is a
generalized disease
with considerable overlap of its coronary, carotid, and peripheral manifestations. As an indicator of multifocal atherosclerosis, peripheral arterial disease (PAD) is emerging as an important aid in risk stratification of patients with coronary artery (
CAD
) or cerebrovascular disease (CVD). Therefore, the aim of the study was to assess the prevalence of PAD in high risk subjects and its ability to identify coronary or cerebrovascular patients. A total of 952 (63.3% male; age 63.7 +/-10.7 years) patients at high cardiovascular risk (>or=2 risk factors), or with evidence of
CAD
or CVD were screened for PAD by means of ankle-brachial index (ABI) assessment; 226 patients were at high risk (>or=2 risk factors), 575 had
CAD
, and 151 had CVD. A total of 42% of patients with
CAD
and 36% of patients with CVD had PAD. In patients with
CAD
one half of cases of PAD were asymptomatic. Asymptomatic PAD (pathological ABI) was strongly associated with
CAD
and CVD, even after adjustment for age, gender, and other risk factors. No significant differences between
CAD
, PAD, and CVD patients were observed in terms of risk profiles. In conclusion, our findings confirm a high prevalence of both symptomatic and asymptomatic PAD in patients at high cardiovascular risk and its association with both
CAD
and CVD.
...
PMID:The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. 1762 85